[Surgical toxico-pharmacological complications during intra-arterial antiblastic therapy of otorhinolaryngological neoplasms].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D003231:Conjunctivitis / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000188:drug therapy*; D010255:Paranasal Sinus Neoplasms / Q000188:drug therapy*; D010264:Paraplegia / Q000139:chemically induced; D010610:Pharyngeal Neoplasms / Q000188:drug therapy*; D014067:Tonsillar Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents
Complicanze chirurgiche e tossico-farmacologiche in corso di terapia antiblastica endo-arteriosa per neoplasie di pertinenza otorinolaringoiatrica.